The development of multifunctional nanoplatforms that are safe and have multiple therapeutic functions integrated with dual- or multi-imaging modality is one of the most urgent medical requirements for active
cancer therapy. In our study, we prepared multifunctional magnetic nanobubbles (MF-
MNBs) by co-encapsulating superparamagnetic iron oxide nanoparticles (SPIONs) and
doxorubicin into polylactideco-glycolide-
polyethylene glycol-
folate (PLGA-PEG-FA)
polymer-based nanobubbles for
tumor-targeted ultrasound (US)/magnetic resonance (MR) imaging and focused ultrasound (FUS)-triggered
drug delivery. Hydrophobic SPIONs were successfully embedded into MF-
MNBs by a typical double
emulsion process. The MF-
MNBs were highly dispersed with well-defined spherical morphology and an average diameter of 208.4 ± 12.58 nm. The potential of MF-MNB as a dual-modal
contrast agent for US and MR imaging was investigated via in vitro study, and the MF-MNB exhibits promising US/MR contrast ability. Moreover,
tumor targeting ability was further enhanced by
folate conjugation and assessed through in vitro cell test. Furthermore, FUS, as a non-invasive and remote-control technique, was adopted to trigger the release of
doxorubicin from MF-MNB and generate the sonoporation effect to enhance drug release and cellular uptake of MF-
MNBs. The 4T1 cell viability was significantly decreased by FA
ligand-receptor-mediated targeting and FUS sonication. In addition, the developed MF-MNB also exhibits enhanced accumulation in
tumor site by FA
ligand-receptor-mediated
tumor targeting, in which the accumulation of MF-MNB was further enhanced by FUS sonication. Hence, we believe that the MF-MNB could be a promising
drug nanocarrier for US/MR-guided anticancer
drug delivery to improve
cancer treatment efficacy.